Response: Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study.
作者信息
Pira Anna, Moltrasio Chiara, Abeni Damiano, Corrà Alberto, Marzano Angelo Valerio, Caproni Marzia, Di Zenzo Giovanni
机构信息
Molecular and Cell Biology Laboratory, Istituto Dermopatico dell'immacolata (IDI)-IRCCS, Rome, Italy.
Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
出版信息
Front Med (Lausanne). 2023 Mar 16;10:1160672. doi: 10.3389/fmed.2023.1160672. eCollection 2023.
Abstract
摘要
相似文献
1
Response: Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study.回应：评论：与新冠疫苗相关的大疱性类天疱疮：一项意大利多中心研究。
Front Med (Lausanne). 2023 Mar 16;10:1160672. doi: 10.3389/fmed.2023.1160672. eCollection 2023.
2
Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study.评论：与新冠疫苗相关的大疱性类天疱疮：一项意大利多中心研究。
Front Med (Lausanne). 2022 Dec 19;9:1096867. doi: 10.3389/fmed.2022.1096867. eCollection 2022.
3
A case of acquired hemophilia A and bullous pemphigoid following SARS-CoV-2 mRNA vaccination.接种 SARS-CoV-2 mRNA 疫苗后出现获得性血友病 A 和大疱性类天疱疮。
J Formos Med Assoc. 2022 Sep;121(9):1872-1876. doi: 10.1016/j.jfma.2022.02.017. Epub 2022 Mar 14.
4
SARS-CoV-2 vaccine-triggered conversion from systemic lupus erythematosus (SLE) to bullous SLE and dipeptidyl peptidase 4 inhibitors-associated bullous pemphigoid.SARS-CoV-2 疫苗引发的系统性红斑狼疮（SLE）向大疱性 SLE 和二肽基肽酶 4 抑制剂相关大疱性类天疱疮的转化。
J Dermatol. 2023 Feb;50(2):162-165. doi: 10.1111/1346-8138.16687. Epub 2022 Dec 28.
5
Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine.阿斯利康新冠疫苗诱发的大疱性类天疱疮。
Ann Dermatol Venereol. 2022 Mar;149(1):56-57. doi: 10.1016/j.annder.2021.07.008. Epub 2021 Sep 30.
6
COVID-19 and autoimmune bullous diseases: Lessons learned.COVID-19 与自身免疫性大疱性疾病：经验教训。
Autoimmun Rev. 2023 Apr;22(4):103286. doi: 10.1016/j.autrev.2023.103286. Epub 2023 Feb 2.
7
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study.大疱性类天疱疮患者的死亡率和预后因素：一项回顾性多中心意大利研究。
J Eur Acad Dermatol Venereol. 2022 Dec;36(12):2473-2481. doi: 10.1111/jdv.18441. Epub 2022 Sep 10.
8
A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccine.1例新型冠状病毒mRNA疫苗接种后发生大疱性类天疱疮的病例。
J Eur Acad Dermatol Venereol. 2022 Jan;36(1):e13-e16. doi: 10.1111/jdv.17676. Epub 2021 Oct 5.
9
Bullous pemphigoid and COVID-19 vaccine.大疱性类天疱疮与新冠疫苗
Med Clin (Barc). 2021 Nov 26;157(10):e333-e334. doi: 10.1016/j.medcli.2021.05.005. Epub 2021 May 27.
10
Bullous pemphigoid triggered by COVID-19 vaccine: Rapid resolution with corticosteroid therapy.由新冠疫苗引发的大疱性类天疱疮：皮质类固醇治疗后迅速消退
Dermatol Ther. 2022 Jan;35(1):e15208. doi: 10.1111/dth.15208. Epub 2021 Nov 30.
引用本文的文献
1
COVID-19 Vaccine: A Potential Risk Factor for Accelerating the Onset of Bullous Pemphigoid.新冠疫苗：加速大疱性类天疱疮发病的潜在风险因素
Vaccines (Basel). 2024 Sep 5;12(9):1016. doi: 10.3390/vaccines12091016.
2
The mRNA-LNP vaccines - the good, the bad and the ugly?mRNA-LNP 疫苗——好、坏、丑？
Front Immunol. 2024 Feb 8;15:1336906. doi: 10.3389/fimmu.2024.1336906. eCollection 2024.
本文引用的文献
1
Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine.新冠疫情期间的自身免疫性大疱性疾病：2022年利妥昔单抗与疫苗最新进展
Front Med (Lausanne). 2023 Jan 19;10:1112823. doi: 10.3389/fmed.2023.1112823. eCollection 2023.
2
Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study.评论：与新冠疫苗相关的大疱性类天疱疮：一项意大利多中心研究。
Front Med (Lausanne). 2022 Dec 19;9:1096867. doi: 10.3389/fmed.2022.1096867. eCollection 2022.
3
Association between COVID-19 vaccination and autoimmune bullous diseases: a random coincidence or rare event.2019冠状病毒病疫苗接种与自身免疫性大疱性疾病之间的关联：随机巧合还是罕见事件。
J Eur Acad Dermatol Venereol. 2022 Sep;36(9):e665-e666. doi: 10.1111/jdv.18202. Epub 2022 May 18.
4
Reply to "New-onset bullous pemphigoid after inactivated Covid-19 vaccine: Synergistic effect of the Covid-19 vaccine and vildagliptin".对“新型冠状病毒灭活疫苗接种后新发大疱性类天疱疮：新型冠状病毒疫苗与维格列汀的协同作用”的回复
Dermatol Ther. 2022 Jun;35(6):e15496. doi: 10.1111/dth.15496. Epub 2022 Apr 10.
5
Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study.与新冠疫苗相关的大疱性类天疱疮：一项意大利多中心研究。
Front Med (Lausanne). 2022 Feb 28;9:841506. doi: 10.3389/fmed.2022.841506. eCollection 2022.
6
Evaluating risk of bullous pemphigoid after mRNA COVID-19 vaccination.评估mRNA新冠疫苗接种后大疱性类天疱疮的风险。
Br J Dermatol. 2022 Aug;187(2):271-273. doi: 10.1111/bjd.21240. Epub 2022 May 24.
7
Absolving COVID-19 Vaccination of Autoimmune Bullous Disease Onset.解除新冠疫苗接种与自身免疫性大疱病发病的关联
Front Immunol. 2022 Feb 18;13:834316. doi: 10.3389/fimmu.2022.834316. eCollection 2022.
8
Case Report: Circulating Anti-SARS-CoV-2 Antibodies Do Not Cross-React With Pemphigus or Pemphigoid Autoantigens.病例报告：循环抗SARS-CoV-2抗体与天疱疮或类天疱疮自身抗原无交叉反应。
Front Med (Lausanne). 2021 Dec 20;8:807711. doi: 10.3389/fmed.2021.807711. eCollection 2021.
9
New-onset autoimmune phenomena post-COVID-19 vaccination.接种 COVID-19 疫苗后出现的新自身免疫现象。
Immunology. 2022 Apr;165(4):386-401. doi: 10.1111/imm.13443. Epub 2022 Jan 7.
10
New-onset bullous pemphigoid after inactivated Covid-19 vaccine: Synergistic effect of the Covid-19 vaccine and vildagliptin.新型冠状病毒灭活疫苗接种后新发大疱性类天疱疮：新型冠状病毒疫苗与维格列汀的协同作用
Dermatol Ther. 2022 Feb;35(2):e15241. doi: 10.1111/dth.15241. Epub 2021 Dec 8.
Zotero 插件